Abstract
Kidney donation after circulatory death (DCD) is a less than ideal option to meet organ shortages. Hypothermic machine perfusion (HMP) with Belzer solution (BS) improves the viability of DCD kidneys, although the graft clinical course remains critical. Mesenchymal stromal cells (MSC) promote tissue repair by releasing extracellular vesicles (EV). We evaluated whether delivering MSC‐/MSC‐derived EV during HMP protects rat DCD kidneys from ischaemic injury and investigated the underlying pathogenic mechanisms. Warm ischaemic isolated kidneys were cold‐perfused (4 hrs) with BS, BS supplemented with MSC or EV. Renal damage was evaluated by histology and renal gene expression by microarray analysis, RT‐PCR. Malondialdehyde, lactate, LDH, glucose and pyruvate were measured in the effluent fluid. MSC‐/EV‐treated kidneys showed significantly less global ischaemic damage. In the MSC/EV groups, there was up‐regulation of three genes encoding enzymes known to improve cell energy metabolism and three genes encoding proteins involved in ion membrane transport. In the effluent fluid, lactate, LDH, MDA and glucose were significantly lower and pyruvate higher in MSC/EV kidneys as compared with BS, suggesting the larger use of energy substrates by MSC/EV kidneys. The addition of MSC/EV to BS during HMP protects the kidney from ischaemic injury by preserving the enzymatic machinery essential for cell viability and protects the kidney from reperfusion damage.
Highlights
The pool of kidneys currently available for transplantation could be expanded with the procurement of organs from the donation after circulatory death (DCD)
To infer the transcriptional changes induced by perfusion, in a preliminary experiment, after warm ischaemia, five non-perfused kidneys (NP) and five Mesenchymal stromal cells (MSC)-perfused kidneys (MSC) were stored in RNA later and processed for microarray gene expression analysis
We report in a rat model of DCD kidney that pre-conditioning with MSC, and even more with MSC-derived extracellular vesicles (EV), results in a significant reduction in renal ischaemic injury
Summary
The core rational behind this application is that delivering MSC- or MSC-derived EV (hereafter named EV) to the isolated kidney, as part of the HMP procedure, prepares renal cells and the environment to face the incoming injury, rather than contrasting the assault once it has fired up. We investigated this novel approach in a rat DCD model and evaluated the morphological, biochemical and molecular effects of MSC/EV on perfused kidneys
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.